Article Text

Download PDFPDF
Resolution of conjunctival Kaposi sarcoma after institution of highly active antiretroviral therapy alone
  1. H A Leder1,
  2. A Galor1,
  3. G B Peters1,
  4. S R Kedhar1,
  5. J P Dunn1,
  6. J E Thorne1,2
  1. 1
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  2. 2
    Department of Epidemiology, Center for Clinical Trials, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
  1. H A Leder, Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, MD, USA; hleder{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We present a case of conjunctival Kaposi sarcoma that resolved after treatment with highly active antiretroviral therapy alone.

Case report

A 53-year-old man from Ghana was diagnosed with human immunodeficiency virus in July 2005 and presented on March 2006 with a 2-week history of itching, redness and pain in the right eye. His examination showed a large, mobile, slightly tender lesion of the conjunctiva, not involving caruncle (fig 1). At that time his CD4+ T cell count was 38 cells/μl. He had simultaneous lesions on his feet consistent with Kaposi sarcoma. Biopsy of his foot …

View Full Text


  • Funding: Supported by grants EY-13707 (J E Thorne) from the National Eye Institute, Bethesda, MD, USA.

  • Competing interests: None.